Penumbra, Inc. (PEN)

NYSE: PEN · Real-Time Price · USD

322.32

-0.65 (-0.20%)

At close: May 15, 2026, 4:00 PM EDT

322.21

-0.11 (-0.03%)

After-hours: May 15, 2026, 7:00 PM EDT

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
United States Revenue	1.13B	1.09B	902.07M
United States Revenue Growth	3.62%	21.03%	19.14%
International Revenue	323.00M	311.90M	292.55M
International Revenue Growth	3.56%	6.62%	-2.93%
Revenue (Other)	-5.00K	6.00K	5.00K
Revenue (Total)	1.45B	1.40B	1.19B
Revenue (Total) Growth	3.61%	17.50%	12.86%

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Thrombectomy Revenue	975.29M	947.92M	815.48M
Thrombectomy Revenue Growth	2.89%	16.24%	20.39%
Embolization and Access Revenue	478.99M	455.75M	379.14M
Embolization and Access Revenue Growth	5.10%	20.21%	-0.53%
Revenue (Other)	-3.00K	5.00K	5.00K
Revenue (Total)	1.45B	1.40B	1.19B
Revenue (Total) Growth	3.61%	17.50%	12.86%

Updated May 6, 2026. Data Source: Fiscal.ai.